Sign inCreate account

Report workspace tools

NCT02131766COMPLETEDanonymous

Unified Safety System (USS) Virginia Closed-Loop Versus Sensor Augmented Pump Therapy for Overnight Control in Type 1 Diabetes

Sponsor

Source record

University of Virginia

Phase

Source record

NA

Modality

AI-normalized

cell therapy

Target

AI-normalized

Type 1 Diabetes

Indication / condition

AI-normalized

Diabetes Mellitus

Intervention

Source record

DiAs, Sensor Augmented Pump Therapy

Source & freshness

Source record

NCT ID

NCT02131766

Original source

ClinicalTrials.gov

Source last updated

Apr 16, 2020

Ingested at

May 23, 2026

Internal sync

Jun 05, 2026

Model version

trialsignal-ai-v1

Normalized confidence

88%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT02131766

Title

Unified Safety System (USS) Virginia Closed-Loop Versus Sensor Augmented Pump Therapy for Overnight Control in Type 1 Diabetes

Sponsor

University of Virginia

Status

COMPLETED

Phase

NA

Condition raw

Diabetes Mellitus

Condition normalized

Diabetes Mellitus

Modality raw

Diabetes Mellitus

Modality normalized

cell therapy

Target raw

Type 1 Diabetes

Target normalized

Type 1 Diabetes

Interventions

DiAs, Sensor Augmented Pump Therapy

Public preview

Source record

The USS Virginia Closed-Loop system aims to improve overnight blood glucose control in adults with Type 1 Diabetes (T1DM) compared to traditional sensor-augmented pump therapy. The study evaluates the feasibility and effectiveness of this system in an outpatient setting.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Unified Safety System (USS) Virginia Closed-Loop Versus Sensor Augmented Pump Therapy for Overnight Control in Type 1 Diabetes

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT02131766

Status

COMPLETED

Phase

NA

Sponsor

University of Virginia

Executive brief

Investment-Ready Snapshot

The USS Virginia Closed-Loop system aims to improve overnight blood glucose control in adults with Type 1 Diabetes (T1DM) compared to traditional sensor-augmented pump therapy. The study evaluates the feasibility and effectiveness of this system in an outpatient setting.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedApr 16, 2020
Internal syncJun 05, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT02131766

Indication

Diabetes Mellitus

Modality

cell therapy

Target

Type 1 Diabetes

Intervention

DiAs, Sensor Augmented Pump Therapy

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.